MedTrace Logo

Obesity Hypoventilation Syndrome Prevalence Study

NCT01964339 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 44

Last updated 2018-12-11

No results posted yet for this study

Summary

This is an observational study to characterize the prevalence of Obesity Hypoventilation Syndrome in patients referred to the sleep lab.

Conditions

  • Obesity Hypoventilation Syndrome

Interventions

OTHER

BMI greater than or equal to 30kg/m2 scheduled for PSG. Undergo blood draw (venous blood gas and metabolic panel) and data collection from PSG study.

Venous blood gas, basic metabolic panel, PSG variable data collection.

OTHER

BMI greater than or equal to 30kg/m2 scheduled for PSG. Undergo blood draw (arterial blood gas and metabolic panel) and data collection from PSG study.

Arterial blood gas, basic metabolic panel, PSG variable data collection

Sponsors & Collaborators

  • Philips Respironics

    lead INDUSTRY

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-10-09
Primary Completion
2014-05-21
Completion
2014-05-21

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01964339 on ClinicalTrials.gov